123 related articles for article (PubMed ID: 8611954)
21. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of the antimitotic properties of cyclophosphamide and its biotransformation products on meristema plant cells and animal cells in in vitro culture].
Deysson G; Adolphe M; Semont H
C R Seances Soc Biol Fil; 1981; 175(2):182-6. PubMed ID: 6454464
[TBL] [Abstract][Full Text] [Related]
23. Reproducibility of methods relating to cyclophosphamide metabolic studies.
Phillipou G; Seaborn CJ; Raniolo E
J Natl Cancer Inst; 1993 Aug; 85(15):1249-51. PubMed ID: 8331687
[No Abstract] [Full Text] [Related]
24. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
25. Half-life of oxazaphosphorines in biological fluids.
Sladek NE; Powers JF; Grage GM
Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
[TBL] [Abstract][Full Text] [Related]
26. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
[TBL] [Abstract][Full Text] [Related]
27. Relative mutagenicity of some urinary metabolites of the antitumor drug cyclophosphamide.
Balbinder E; Reich CI; Shugarts D; Keogh J; Fibiger R; Jones T; Banks A
Cancer Res; 1981 Jul; 41(7):2967-72. PubMed ID: 7018675
[TBL] [Abstract][Full Text] [Related]
28. Covalent sequestration of phosphoramide mustard by metallothionein--an in vitro study.
Wei D; Fabris D; Fenselau C
Drug Metab Dispos; 1999 Jul; 27(7):786-91. PubMed ID: 10383921
[TBL] [Abstract][Full Text] [Related]
29. Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites.
Jardine I; Brundrett R; Colvin M; Fenselau C
Cancer Treat Rep; 1976 Apr; 60(4):403-8. PubMed ID: 1277214
[TBL] [Abstract][Full Text] [Related]
30. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients.
Tasso MJ; Boddy AV; Price L; Wyllie RA; Pearson AD; Idle JR
Cancer Chemother Pharmacol; 1992; 30(3):207-11. PubMed ID: 1628369
[TBL] [Abstract][Full Text] [Related]
32. Gas chromatographic-mass spectrometric assay for N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in rat plasma.
Lu H; Chan KK
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):219-25. PubMed ID: 8738025
[TBL] [Abstract][Full Text] [Related]
33. Influence of dietary carrot on cytostatic drug activity of cyclophosphamide and its main directly acting metabolite: induction of sister-chromatid exchanges in normal human lymphocytes, Chinese hamster ovary cells, and their DNA repair-deficient cell lines.
Darroudi F; Targa H; Natarajan AT
Mutat Res; 1988 Apr; 198(2):327-35. PubMed ID: 3352640
[TBL] [Abstract][Full Text] [Related]
34. Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatography.
Huitema AD; Tibben MM; Kerbusch T; Kettenes-van den Bosch JJ; Rodenhuis S; Beijnen JH
J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(2):345-55. PubMed ID: 11043753
[TBL] [Abstract][Full Text] [Related]
35. The analysis of cyclophosphamide and its metabolites.
Malet-Martino M; Gilard V; Martino R
Curr Pharm Des; 1999 Aug; 5(8):561-86. PubMed ID: 10469892
[TBL] [Abstract][Full Text] [Related]
36. Analysis of cyclophosphamide and five metabolites from human plasma using liquid chromatography-mass spectrometry and gas chromatography-nitrogen-phosphorus detection.
Kalhorn TF; Ren S; Howald WN; Lawrence RF; Slattery JT
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):287-98. PubMed ID: 10517350
[TBL] [Abstract][Full Text] [Related]
37. O-Methylhydroxylamine as a new trapping reagent for quantitative studies of 4-hydroxycyclophosphamide and aldophosphamide.
Zon G; Ludeman SM; Sweet EM; Egan W; Phillips LR
J Pharm Sci; 1982 Apr; 71(4):443-6. PubMed ID: 7086655
[TBL] [Abstract][Full Text] [Related]
38. Enzymatic detoxification of phosphoramide mustard by soluble fractions from rat organ tissues.
Hong PS; Chan KK
Drug Metab Dispos; 1991; 19(3):568-73. PubMed ID: 1680621
[TBL] [Abstract][Full Text] [Related]
39. 31P nuclear magnetic resonance spectroscopic observation of the intracellular transformations of oncostatic cyclophosphamide metabolites.
Boyd VL; Robbins JD; Egan W; Ludeman SM
J Med Chem; 1986 Jul; 29(7):1206-10. PubMed ID: 3543359
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of high doses of cyclophosphamide.
Milsted RA; Jarman M
Cancer Chemother Pharmacol; 1982; 8(3):311-3. PubMed ID: 7127662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
